M V Blagosklonny
- Oncology top 10%
- Cancer-related Molecular Pathways 3
- Cancer Cells and Metastasis 2
- Biotechnology top 5%
- Cell Biology top 10%
- Microtubule and mitosis dynamics 2
-
- Protein Kinase Regulation and GTPase Signaling 1
- Cell death mechanisms and regulation 1
- DNA and Nucleic Acid Chemistry 1
- DNA Repair Mechanisms 1
-
- Hormonal and reproductive studies 1
- Co-authors
- Len NeckersTim SchulteJ. B. TrepelP NguyenTito FojoMarianne S. PoruchynskyCharles M. RudinZoya N. Demidenko
- Cited by
- OncologyBiotechnologyCell Biology
- Journals
- Oncogene (1 paper)British Journal of Cancer (1 paper)Cell Death and Differentiation (1 paper)
- Partner nations
- United States
In The Last Decade
M V Blagosklonny
11 papers receiving 964 citations
Peers
Comparison fields: 5 of 83
- Oncology 426
- Biotechnology 121
- Cell Biology 190
- Cancer Research 130
- Molecular Biology 574
Countries citing papers authored by M V Blagosklonny
This map shows the geographic impact of M V Blagosklonny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M V Blagosklonny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M V Blagosklonny more than expected).
Fields of papers citing papers by M V Blagosklonny
This network shows the impact of papers produced by M V Blagosklonny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M V Blagosklonny. The network helps show where M V Blagosklonny may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M V Blagosklonny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 89 | |
| 2 | 2005 | 64 | |
| 3 | 2005 | 153 | |
| 4 | 2003 | 73 | |
| 5 | The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel. | 2001 | 35 |
| 6 | A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer. | 1999 | 78 |
| 7 | Bcl-xL is phosphorylated in malignant cells following microtubule disruption. | 1998 | 135 |
| 8 | Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. | 1996 | 342 |
| 9 | The role of Bcl-2 protein and autocrine growth factors in a human follicular lymphoma-derived B cell line. | 1995 | 5 |
| 10 | Oligonucleotides protect cells from the cytotoxicity of several anti-cancer chemotherapeutic drugs. | 1994 | 11 |
| 11 | Sensitive and simple bioassay for human tumour necrosis factor-alpha. | 1994 | 4 |
About M V Blagosklonny
M V Blagosklonny is a scholar working on Oncology, Immunology and Allergy and Immunology, having authored 11 papers that have together received 989 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Cancer Cells and Metastasis (2 papers), Microtubule and mitosis dynamics (2 papers), Hormonal and reproductive studies (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Cell death mechanisms and regulation (1 paper), DNA and Nucleic Acid Chemistry (1 paper) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Oncology (426 citations), Biotechnology (121 citations) and Cell Biology (190 citations). M V Blagosklonny has collaborated with scholars based in United States. Frequent co-authors include Len Neckers, Tim Schulte, J. B. Trepel, P Nguyen, Tito Fojo, Marianne S. Poruchynsky, Charles M. Rudin, Zoya N. Demidenko, Eugenia V. Broude and Swathi Kalurupalle. Their work appears in journals such as Oncogene, British Journal of Cancer and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.